The Kingdom of Saudi Arabia will host the Middle East edition of the ‘BIO / CPHI’ Biotechnology and Pharmaceutical Development Forum in Riyadh under the patronage of the Ministry of Health and organized by Tahaluf Company.
The BIO / CPHI event will take place from May 11 to 13 at the Riyadh Convention and Exhibition Center in Malham, bringing together global leaders in biotechnology and pharmaceutical development.
Hosting the BIO / CPHI forum reflects growing international confidence in Saudi Arabia’s healthcare investment landscape and progressive regulatory framework, reinforcing the Kingdom’s ambition to lead regional transformation in biotechnology and pharmaceutical development.
The event aligns with Saudi Vision 2030’s goals of building a diversified, innovation-driven economy and strengthening the sustainability and global competitiveness of the healthcare sector.
The BIO / CPHI forum will bring together more than 60,000 participants from over 100 countries and over 1,000 leading global and regional brands, including industry leaders, policymakers, investors, researchers, manufacturers, and innovators. The event will create a dynamic international gathering that reflects the rapid growth and strategic importance of the biotechnology and pharmaceutical sectors worldwide.
The forum will serve as a comprehensive global platform for knowledge exchange, high-level dialogue, investment opportunities, and strategic partnerships, while showcasing the latest scientific breakthroughs, advanced technologies, and cutting-edge solutions across the entire biotechnology and pharmaceutical value chain.
Through the event, the Ministry of Health aims to accelerate pharmaceutical localization, boost the healthcare sector’s contribution to GDP, expand health investments, and develop national talent. It also seeks to strengthen international collaboration and position the Kingdom as a globally competitive hub for life sciences and healthcare innovation.
